Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05778695 · ClinicalTrials.gov registry record · NA
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05778695 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 16 participants.
The verdict
NCT05778695, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Small exploratory open-label pilot study to assess supplementation of a ketone ester (KetoneAid) as a potential therapy for persons with Parkinson disease (PD), Parkinson Disease Dementia/Lewy Body Dementia (PDD/LBD), and healthy controls.
Interventions
- DIETARY_SUPPLEMENT Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-03-09 |
| Est. Completion | 2023-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05778695
The ClinicalTrials.gov registry entry for NCT05778695 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate is the first listed.
NCT05778695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05778695 about?
NCT05778695 is a clinical study titled "Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones". Small exploratory open-label pilot study to assess supplementation of a ketone ester (KetoneAid) as a potential therapy for persons with Parkinson disease (PD), Parkinson Disease Dementia/Lewy Body Dementia (PDD/LBD), and healthy controls.
What is the current status of trial NCT05778695?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2023-03-09. Estimated completion is 2023-10-04.
What interventions are being tested in trial NCT05778695?
The interventions under investigation include: Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05778695?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.